Cover Image
市場調查報告書

生物學的植入市場規模與預測:各產品(自體移植片,異體移植片,異質骨移植),各用途(心血管,整形外科,牙科,皮膚科植入),各投藥法(注射,外科),及趨勢分析

Biological Implants Market Size And Forecast By Product (Autografts, Allografts, Xenografts), By Application (Cardiovascular Orthopedic, Dental, & Dermal Implants), By Mode Of Administration (Injectable & Surgical)' And Trend Analysis From 2013 To 2024

出版商 Grand View Research, Inc. 商品編碼 398879
出版日期 內容資訊 英文 147 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物學的植入市場規模與預測:各產品(自體移植片,異體移植片,異質骨移植),各用途(心血管,整形外科,牙科,皮膚科植入),各投藥法(注射,外科),及趨勢分析 Biological Implants Market Size And Forecast By Product (Autografts, Allografts, Xenografts), By Application (Cardiovascular Orthopedic, Dental, & Dermal Implants), By Mode Of Administration (Injectable & Surgical)' And Trend Analysis From 2013 To 2024
出版日期: 2016年10月24日 內容資訊: 英文 147 Pages
簡介

本報告提供生物學的植入市場相關調查,市場趨勢與各產品,各投藥法,各地區預測,競爭趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場區隔和範圍
    • 促進要素分析
    • 阻礙要素分析
  • 滲透率與成長預測製圖
  • SWOT分析
  • 波特五力分析

第4章 市場類別1:各產品預測與趨勢分析

  • 各產品趨勢分析
  • 自體移植片
  • 異體移植片
  • 異質骨移植

第5章 市場類別2:各用途預測與趨勢分析

  • 各類型趨勢分析
  • 心血管植入
  • 整形外科移植
  • 其他軟組織植入

第6章 市場類別3:各投藥法預測與趨勢分析

  • 各投藥法趨勢分析
  • 外科的植入
  • 注射型植入

第7章 市場類別4:各地區預測與趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭環境

  • 策略性架構
  • 市場進入分類
  • 企業簡介
    • Integra LifeSciences Corporation
    • NuVasive, Inc
    • Edward LifeSciences Corporation
    • Stryker Corporation
    • LifeCell corporation
    • Medtronic
    • RTI Surgical, Inc
    • BioPolymer GmbH & Co. KG
    • Johnson & Johnson
    • Baxter International, Inc.
    • Vericel Corporation
    • Alphatec Spine, Inc
    • CryoLife
    • Maxigen Biotech, Inc.
    • IOP Ophthalmic Products, Inc.
    • CONMED
    • Allergan Plc
    • BioTissue
    • Auto Tissue Berlin GmbH
    • MiMedx Group, Inc.
    • Organogenesis, Inc.
    • Osiris Therapeutics, Inc.

圖表

目錄
Product Code: GVR-1-68038-270-9

Global biological implant market is anticipated to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Modification in the process of composite grafting is expected to play a crucial role in tackling reimplantation of amputated fingertips by bringing development in the overall process of grafting. Moreover, rising competition amongst key participants operating in this market is one of the high impact rendering factors to accelerate the growth.

Further key findings from the report suggest:

  • Depending upon the source or donor of grafts, products offered can be categorized into autograft, allografts, and xenografts. Xenografts dominated the revenue share in 2015 with a revenue share of over 50%. However, allografts are expected to witness the fastest growth owing to the fact that they are derived from same species and produce considerably less chances of foreign immune reaction, thereby influencing adoption rate.
  • Biological implants serve various application domains which include cardiovascular, orthopedic, and other soft tissue implants. Soft tissue products accounted for the largest share in 2015 as a result of higher usage of the products in the field of dentistry. Even though cardiovascular implants accounted for lowest penetration in the current scenario, demand for cardiovascular stents and valves obtained from biological source is expected to expand, consequently boosting revenue generation from this segment.
  • Amongst surgical and injectable mode of administration, surgical mode is estimated to hold the larger share, as a consequence of availability of several products administered via this route. Introduction of minimally invasive techniques for surgical incorporation of grafts is also one of the significant factors propelling growth in this segment.
  • North America dominated the market with a revenue share of 50% due to widespread presence of participants coupled with high aesthetic and healthcare awareness levels amongst the population in this region.
  • Asia Pacific is estimated to exhibit the fastest growth in the coming years due to presence of the target population and rapidly improving health care infrastructure which is attributed to drive the demand for tissue engineered products and biological implants.
  • Major players operating in this industry include Medtronic, NuVasive, Inc, Stryker Corporation, Conmed Corporation, CryoLife, Edwards LifeSciences Corporation, Acelity, Integra LifeSciences Corporation, Allergan Plc, RTI Surgical, IOP Ophthalmics, Organogenesis Inc, BioPolymer GmbH & Co. KG, Osiris Therapeutics, Baxter International, Vericel, Aplhatec Spine Inc, Maxigen Biotech Inc, Auto Tissue Berlin GmbH, MiMedx Group, Inc., Biotissue Technologies,
  • These players are undertaking different business strategies to boost their respective penetration and enhance market presence. These strategies include novel product developments and geographic expansion by involving in collaborative activities in order to grab the larger share of revenue. For instance, in April 2016, Stryker Corporation acquired Stanmore Implants Worldwide Limited which is expected to enable the company to provide differentiated technologies to orthopedic oncology surgeons, thus propelling growth over the forecast period.

Table of Content

Chapter 1. Research Methodology

  • 1.1. Information procurement
  • 1.2. Data Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Market Variables, Trends& Scope

  • 3.1. Market segmentation & scope
    • 3.1.1. Market Driver Analysis
      • 3.1.1.1. Technological advancements in biological implants
      • 3.1.1.2. Rising market competition amongst prominent market entities
      • 3.1.1.3. Development in composite grafting
      • 3.1.1.4. Rising demand as a consequence of accidental injuries
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. High manufacturing cost associated with implants
      • 3.1.2.2. Hesitant uptake due to adverse events
  • 3.2. Penetration & growth prospect mapping, 2015& 2024
  • 3.3. Biological implants- SWOT Analysis, By Factor(political & legal, economic and technological)
  • 3.4. Industry Analysis-Porter's

Chapter 4. Market Categorization 1: Product Estimates & Trend Analysis

  • 4.1. Biological implantsmarket: product movement analysis
  • 4.2. Autografts
    • 4.2.1. Global autografts implants market, 2013-2024(USD million)
  • 4.3. Allografts
    • 4.3.1. Global allografts market, 2013-2024(USD million)
  • 4.4. Xenografts
    • 4.4.1. Global xenografts market, 2013-2024(USD million)

Chapter 5. Market Categorization 2: Application Estimates & Trend Analysis

  • 5.1. Biological implantsmarket: Application movement analysis
  • 5.2. Cardiovascular implants
    • 5.2.1. Global cardiovascular implants market, 2013-2024(USD million)
  • 5.3. Orthopedic implants
    • 5.3.1. Global orthopedic implants market, 2013-2024(USD million)
  • 5.4. Other soft tissue implants
    • 5.4.1. Global other soft tissue implants market, 2013-2024(USD million)

Chapter 6. Market Categorization 3: Mode of administration Estimates & Trend Analysis

  • 6.1. Biological implants market: Mode of administration movement analysis
  • 6.2. Surgical biological implants
    • 6.2.1. Global surgical biological implant market, 2013-2024(USD million)
  • 6.3. Injectable biological implant
    • 6.3.1. Global injectable biological implant market, 2013-2024(USD million)

Chapter 7. Market Categorization 4: Regional Estimates & Trend Analysis, by Product & Application

  • 7.1. Biological implants market shares by region, 2015& 2024
  • 7.2. North America
    • 7.2.1. North America biological implantsmarket, 2013-2024(USD million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. biological implantsmarket, 2013-2024(USD million)
    • 7.2.3. Canada.
      • 7.2.3.1. Canada biological implantsmarket, 2013-2024(USD million)
  • 7.3. Europe
    • 7.3.1. Europe biological implantsmarket, 2013-2024(USD million)
    • 7.3.2. Germany
      • 7.3.2.1. Germany biological implantsmarket, 2013-2024(USD million)
    • 7.3.3. UK
      • 7.3.3.1. UK biological implantsmarket, 2013-2024(USD million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific biological implantsmarket, 2013-2024(USD million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan biological implantsmarket, 2013-2024(USD million)
    • 7.4.3. China
      • 7.4.3.1. China biological implantsmarket, 2013-2024(USD million)
  • 7.5. Latin America
    • 7.5.1. Latin America biological implantsmarket, 2013-2024(USD million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazilbiological implantsmarket, 2013-2024(USD million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa biological implantsmarket, 2013-2024(USD million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa biological implantsmarket, 2013-2024(USD million)

Chapter 8. Competitive Landscape

  • 8.1. Strategy framework
  • 8.2. Market participation categorization
  • 8.3. Company Profiles
    • 8.3.1. Integra LifeSciences Corporation
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. NuVasive, Inc
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Edward LifeSciences Corporation
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. LifeCell corporation
      • 8.3.5.1. Company overview
      • 8.3.5.1.1. Acelity
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Medtronic
      • 8.3.6.1. Company overview
      • 8.3.6.1.1. Covidien plc
      • 8.3.6.1.2. Osteotec Ltd
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. RTI Surgical, Inc
      • 8.3.7.1. Company overview
      • 8.3.7.1.1. Pioneer Surgical Technology
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. BioPolymer GmbH & Co. KG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
    • 8.3.9. Johnson & Johnson
      • 8.3.9.1. Company overview
      • 8.3.9.1.1. DePuy Synthes, Inc.
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Baxter International, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.1.1. Synovis Micro Companies Alliance, Inc
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
    • 8.3.11. Vericel Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Alphatec Spine, Inc
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. CryoLife
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Maxigen Biotech, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
    • 8.3.15. IOP Ophthalmic Products, Inc.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
    • 8.3.16. CONMED
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. Product benchmarking
      • 8.3.16.4. Strategic initiatives
    • 8.3.17. Allergan Plc
      • 8.3.17.1. Company overview
      • 8.3.17.2. Financial performance
      • 8.3.17.3. Product benchmarking
      • 8.3.17.4. Strategic initiatives
    • 8.3.18. BioTissue
      • 8.3.18.1. Company overview
      • 8.3.18.2. Financial performance
      • 8.3.18.3. Product benchmarking
      • 8.3.18.4. Strategic initiatives
    • 8.3.19. Auto Tissue Berlin GmbH
      • 8.3.19.1. Company overview
      • 8.3.19.2. Financial performance
      • 8.3.19.3. Product benchmarking
    • 8.3.20. MiMedx Group, Inc.
      • 8.3.20.1. Company overview
      • 8.3.20.2. Financial performance
      • 8.3.20.3. Product benchmarking
      • 8.3.20.4. Strategic initiatives
    • 8.3.21. Organogenesis, Inc.
      • 8.3.21.1. Company overview
      • 8.3.21.2. Financial performance
      • 8.3.21.3. Product benchmarking
      • 8.3.21.4. Strategic initiatives
    • 8.3.22. Osiris Therapeutics, Inc.
      • 8.3.22.1. Company overview
      • 8.3.22.2. Financial performance
      • 8.3.22.3. Product benchmarking
      • 8.3.22.4. Strategic initiatives

List of Tables

  • TABLE 1: Death rate per 100,000 people due to road accidents in Asia Pacific region in 2014
  • TABLE 2: North America biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 3: North America biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 4: North America biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 5: North America biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 6: North America biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 7: North America biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 8: U.S. biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 9: U.S biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 10: U.S biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 11: U.S biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 12: U.S. biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 13: U.Sbiological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 14: Canada biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 15: Canada biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 16: Canada biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 17: Canada biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 18: Canada biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 19: Canada biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 20: Europe biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 21: Europe biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 22: Europe biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 23: Europe biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 24: Europe biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 25: Europe biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 26: Germany biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 27: Germany biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 28: Germany biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 29: Germany biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 30: Germany biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 31: Germany biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 32: UK biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 33: UK biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 34: UK biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 35: UK biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 36: UK biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 37: UK biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 38: Asia Pacific biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 39: Asia Pacific biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 40: Asia Pacific biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 41: Asia Pacific biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 42: Asia Pacific biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 43: Asia Pacific biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 44: Japan biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 45: Japan biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 46: Japan biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 47: Japan biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 48: Japan biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 49: Japan biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 50: China biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 51: China biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 52: China biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 53: China biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 54: China biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 55: China biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 56: Latin America biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 57: Latin America biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 58: Latin America biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 59: Latin America biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 60: Latin America biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 61: Latin America biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 62: Brazil biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 63: Brazil biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 64: Brazil biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 65: Brazil biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 66: Brazil biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 67: Brazil biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 68: Middle East & Africa biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 69: Middle East & Africa biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 70: Middle East & Africa biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 71: Middle East & Africa biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 72: Middle East & Africa biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 73: Middle East & Africa biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)
  • TABLE 74: South Africa biological implants market estimates, by product, 2013 - 2015 (USD million)
  • TABLE 75: South Africa biological implants market forecasts, by product, 2016 - 2024 (USD million)
  • TABLE 76: South Africa biological implants market estimates, by application, 2013 - 2015 (USD million)
  • TABLE 77: South Africa biological implants market forecasts, by application, 2016 - 2024 (USD million)
  • TABLE 78: South Africa biological implants market estimates, by mode of administration, 2013 - 2015 (USD million)
  • TABLE 79: South Africa biological implants market forecasts, by mode of administration, 2016 - 2024 (USD million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Primary research pattern
  • FIG. 4: Market research approaches
  • FIG. 5: Value chain based sizing & forecasting
  • FIG. 6: QFD modelling for market share assessment
  • FIG. 7: Market summary
  • FIG. 8: Market trends & outlook
  • FIG. 9: Market segmentation & scope
  • FIG. 10: Market driver relevance analysis (Current & future impact)
  • FIG. 11: Market restraint relevance analysis (Current & future impact)
  • FIG. 12: Penetration & growth prospect mapping for products, 2015& 2024
  • FIG. 13: SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 14: Porter's Five Forces Analysis
  • FIG. 15: Biological implants market product outlook key takeaways
  • FIG. 16: Biological implants market: Product movement analysis
  • FIG. 17: Global autografts market, 2013 - 2024 (USD million)
  • FIG. 18: Global allografts market, 2013 - 2024 (USD million)
  • FIG. 19: Global xenograftsmarket, 2013 - 2024 (USD million)
  • FIG. 20: Biological implants market:Application outlook key takeaways
  • FIG. 21: Global biological implants market: Application movement analysis
  • FIG. 22: Global cardiovascular implants market, 2013 - 2024 (USD million)
  • FIG. 23: Globalorthopedic implants market, 2013 - 2024 (USD million)
  • FIG. 24: Global other soft tissue implants market, 2013 - 2024 (USD million)
  • FIG. 25: Biological implants market: Mode of administration outlook key takeaways
  • FIG. 26: Global Biological implants market: Mode of administration movement analysis
  • FIG. 27: Global surgical biological implant market, 2013 - 2024 (USD million)
  • FIG. 28: Global injectable biological implant market, 2013 - 2024 (USD million)
  • FIG. 29: Regionalmarket place: Key takeaway
  • FIG. 30: Biological implants regional outlook, 2015 & 2024
  • FIG. 31: North America biological implants market, 2013 - 2024 (USD million)
  • FIG. 32: U.S. biological implants market, 2013 - 2024 (USD million)
  • FIG. 33: Canadabiological implants market, 2013 - 2024 (USD million)
  • FIG. 34: Europe biological implants market, 2013 - 2024 (USD million)
  • FIG. 35: Germany. biological implants market, 2013 - 2024 (USD million)
  • FIG. 36: UK. biological implants market, 2013 - 2024 (USD million)
  • FIG. 37: Asia Pacific. biological implants market, 2013 - 2024 (USD million)
  • FIG. 38: Japan biological implants market, 2013 - 2024 (USD million)
  • FIG. 39: China biological implants market, 2013 - 2024 (USD million)
  • FIG. 40: Latin America biological implants market, 2013 - 2024 (USD million)
  • FIG. 41: Brazil biological implants market, 2013 - 2024 (USD million)
  • FIG. 42: Middle East & Africa biological implants market, 2013 - 2024 (USD million)
  • FIG. 43: South Africa biological implants market, 2013 - 2024 (USD million)
  • FIG. 44: Strategy framework
  • FIG. 45: Participant categorization
Back to Top